Deciphering differential biomarkers for anti-interleukin-6 receptor and anti-tumour necrosis factor-α treatment response in rheumatoid arthritis by multiomics analysis by Emilie Gerard, Michel Didier, Matthias Herrmann, Inoncent Agueusop, Daniel Margerie, Anne Remaury, Raphaël Brard, Francesca Frau, Gilbert Thill, Yaligara Veeranagouda, Markus Kohlmann, Nadine Biesemann

Get full text

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis by Alexander Vugler, James O’Connell, Mai Anh Nguyen, Dietmar Weitz, Thomas Leeuw, Elizabeth Hickford, Alexander Verbitsky, Xiaoyou Ying, Markus Rehberg, Bruce Carrington, Mark Merriman, Andrew Moss, Jean-Marie Nicholas, Phil Stanley, Sara Wright, Tim Bourne, Yann Foricher, Zhaoning Zhu, Daniel Brookings, Helen Horsley, Jag Heer, Laurent Schio, Matthias Herrmann, Srinivas Rao, Markus Kohlmann, Peter Florian

Get full text

Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa by Thomas Leeuw, PhD, Deimantė Šimaitė, PhD, Karen Heyninck, PhD, Clement Levin, PhD, Sigrid Cornelis, PhD, Youssef Hijazi, PhD, Heidi Rommelaere, PhD, Thomas Kreutzberg, PhD, Peter Florian, DVM, Markus Kohlmann, PhD, Theresa-Charlotte Brembach, PhD, Frank Nestle, MD, FmedSci, Kerstin Wolk, PhD, Robert Sabat, MD, PhD, Matthias Herrmann, PhD

Get full text